Beijing Fellow Partners Investment presented its AI healthcare application, 全诊通 (QuanZhenTong), at the Chinese Anti-Cancer Association Translational Medicine Conference. The CEO, Xue Chong, revealed insights into the effectiveness of AI in medical applications. The firm highlighted that 50% of the technology is leveraging AI advancements in the field.
Healthcare Technology, Private Equity, Artificial Intelligence,China
http://www.fellowcap.com/?m=news&a=detail&id=424